- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer ; volume:8 ; number:1 ; day:9 ; month:5 ; year:2015 ; pages:1-8 ; date:12.2015
Journal of ovarian research ; 8, Heft 1 (9.5.2015), 1-8, 12.2015
- Creator
-
Chen, Cong
Ge, Jing
Lu, Qibin
Ping, Guoqiang
Yang, Chunqing
Fang, Xuefeng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-015-0155-1
- URN
-
urn:nbn:de:101:1-2021090318513533817236
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Cong
- Ge, Jing
- Lu, Qibin
- Ping, Guoqiang
- Yang, Chunqing
- Fang, Xuefeng
- SpringerLink (Online service)
Other Objects (12)
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Molecular mechanisms involved in lysine-specific demethylase 1 mediated oncogenic stress
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Role of lysine-specific histone demethylase 1a for kidney development and maintenance
Lysine-specific demethylase 1 regulates differentiation onset and migration of trophoblast stem cells
Lysine-specific histone demethylase 1 (LSD1): a novel molecular target for tumor therapy
The oncogenic role of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
The Role of the Lysine-Specific Demethylase 1 in the Development of Hepatocellular Carcinoma
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Molecular mechanisms involved in lysine-specific demethylase 1 mediated oncogenic stress
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Role of lysine-specific histone demethylase 1a for kidney development and maintenance
Lysine-specific demethylase 1 regulates differentiation onset and migration of trophoblast stem cells
Lysine-specific histone demethylase 1 (LSD1): a novel molecular target for tumor therapy
The oncogenic role of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
The Role of the Lysine-Specific Demethylase 1 in the Development of Hepatocellular Carcinoma
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Molecular mechanisms involved in lysine-specific demethylase 1 mediated oncogenic stress
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Role of lysine-specific histone demethylase 1a for kidney development and maintenance
Lysine-specific demethylase 1 regulates differentiation onset and migration of trophoblast stem cells
Lysine-specific histone demethylase 1 (LSD1): a novel molecular target for tumor therapy
The oncogenic role of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases